These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25225290)

  • 1. A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells.
    Bailey TA; Luan H; Tom E; Bielecki TA; Mohapatra B; Ahmad G; George M; Kelly DL; Natarajan A; Raja SM; Band V; Band H
    J Biol Chem; 2014 Oct; 289(44):30443-30458. PubMed ID: 25225290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C mediated internalization of ErbB2 is independent of clathrin, ubiquitination and Hsp90 dissociation.
    Dietrich M; Malik MS; Nikolaysen F; Skeie M; Stang E
    Exp Cell Res; 2018 Oct; 371(1):139-150. PubMed ID: 30098331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C regulates ErbB3 turnover.
    Dietrich M; Malik MS; Skeie M; Bertelsen V; Stang E
    Exp Cell Res; 2019 Sep; 382(2):111473. PubMed ID: 31233741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.
    Zhang J; Liu S; Li Q; Shi Y; Wu Y; Liu F; Wang S; Zaky MY; Yousuf W; Sun Q; Guo D; Wang T; Zhang Y; Wang Y; Li M; Liu H
    Cell Death Differ; 2020 Sep; 27(9):2710-2725. PubMed ID: 32327714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments.
    Cortese K; Howes MT; Lundmark R; Tagliatti E; Bagnato P; Petrelli A; Bono M; McMahon HT; Parton RG; Tacchetti C
    Mol Biol Cell; 2013 Jan; 24(2):129-44. PubMed ID: 23154999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of sequestration of protein kinase C alpha/betaII by ceramide. Roles of ceramide-activated protein phosphatases and phosphorylation/dephosphorylation of protein kinase C alpha/betaII on threonine 638/641.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    J Biol Chem; 2007 Jul; 282(28):20647-56. PubMed ID: 17504762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells.
    Barr DJ; Ostermeyer-Fay AG; Matundan RA; Brown DA
    J Cell Sci; 2008 Oct; 121(Pt 19):3155-66. PubMed ID: 18765569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
    Asp N; Pust S; Sandvig K
    Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells.
    Castagnola P; Bellese G; Birocchi F; Gagliani MC; Tacchetti C; Cortese K
    Oncotarget; 2016 Dec; 7(51):85411-85429. PubMed ID: 27863425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells.
    Kobayashi Y; Bridle KR; Ramm GA; O'neill R; Britton RS; Bacon BR
    Liver Int; 2007 Oct; 27(8):1066-75. PubMed ID: 17845534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1.
    Zsebik B; Citri A; Isola J; Yarden Y; Szöllosi J; Vereb G
    Immunol Lett; 2006 Apr; 104(1-2):146-55. PubMed ID: 16384610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells.
    Zhang Y; Zhang J; Liu C; Du S; Feng L; Luan X; Zhang Y; Shi Y; Wang T; Wu Y; Cheng W; Meng S; Li M; Liu H
    Cancer Lett; 2016 Nov; 382(2):176-185. PubMed ID: 27597738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin.
    Austin CD; De Mazière AM; Pisacane PI; van Dijk SM; Eigenbrot C; Sliwkowski MX; Klumperman J; Scheller RH
    Mol Biol Cell; 2004 Dec; 15(12):5268-82. PubMed ID: 15385631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
    Bourguignon LY; Gilad E; Peyrollier K
    J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinaseCdelta-calmodulin crosstalk regulates epidermal growth factor receptor exit from early endosomes.
    Lladó A; Tebar F; Calvo M; Moretó J; Sorkin A; Enrich C
    Mol Biol Cell; 2004 Nov; 15(11):4877-91. PubMed ID: 15342779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway.
    Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
    J Cell Physiol; 2018 Mar; 233(3):2526-2536. PubMed ID: 28777435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of protein kinase C alpha is necessary for sorting the PDGF beta-receptor to Rab4a-dependent recycling.
    Hellberg C; Schmees C; Karlsson S; Ahgren A; Heldin CH
    Mol Biol Cell; 2009 Jun; 20(12):2856-63. PubMed ID: 19369415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells.
    Fan Y; Li J; Zhang YQ; Jiang LH; Zhang YN; Yan CQ
    Neurol Res; 2014 Jan; 36(1):53-64. PubMed ID: 24107416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin.
    Muscella A; Vetrugno C; Antonaci G; Cossa LG; Marsigliante S
    Biochem Pharmacol; 2015 Nov; 98(1):29-40. PubMed ID: 26300055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.